Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Stefan Sillau to Adult

This is a "connection" page, showing publications Stefan Sillau has written about Adult.

 
Connection Strength
  
 
 
0.397
  
  1. Sillau SH, Coughlan C, Ahmed MM, Nair K, Araya P, Galbraith MD, Ritchie A, Ching-Jung Wang A, Elos MT, Bettcher BM, Espinosa JM, Chial HJ, Epperson N, Boyd TD, Potter H. Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer's disease by GM-CSF treatment. Cell Rep Med. 2026 Jan 20; 7(1):102525.
    View in: PubMed
    Score: 0.046
  2. Berry A, Watson M, Moore M, Woodward J, Sillau S, Libbon R, Pennetti A, Strom L. Patient reported outcome measures following group and individual therapy in a multidisciplinary functional/dissociative seizure program. Epilepsy Behav. 2026 Oct; 183:111164.
    View in: PubMed
    Score: 0.012
  3. Pellinen J, Sillau S, Bui A, Danciutiu A, Kaye L, Sood A, Ferrari L, Rosenfeld WE, Elder C. Delayed and deferred surgery associated with cenobamate use in people with drug-resistant focal epilepsy. Epilepsia. 2026 Jul; 67(7):3410-3419.
    View in: PubMed
    Score: 0.012
  4. Kammeyer R, Sillau S, Chapman K, Lindwall JJ, Hutaff-Lee C, Schreiner T. Self-reported quality of life related to cognitive function and fatigue in adults with multiple sclerosis. Mult Scler Relat Disord. 2025 Dec; 104:106809.
    View in: PubMed
    Score: 0.011
  5. Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien T, Penovich P, French J, Knupp KG, Holmes M, Barnard S, Kanner AM, Meador KJ. Pre-treatment seizures and cognition at the time of focal epilepsy diagnosis. Epilepsy Behav. 2025 Nov; 172:110746.
    View in: PubMed
    Score: 0.011
  6. Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien TJ, Penovich P, French J, Knupp KG, Barnard S, Holmes M, Hegde M, Kanner AM, Meador KJ. Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistance. Epilepsy Behav. 2025 Mar; 164:110293.
    View in: PubMed
    Score: 0.011
  7. Thompson Iii GR, Chastain DB, Ferraz C, Alhayek S, Salinas JL, Sillau S, Stenehjem EA, Henao-Martínez AF. Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network. Med Mycol. 2024 Dec 27; 63(1).
    View in: PubMed
    Score: 0.011
  8. Carlson AM, Sollero CEV, Wolf AB, Sillau S, Schmitt BL, Money KM, Nair KV, Piquet AL, Bennett JL. The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population. Ann Clin Transl Neurol. 2025 01; 12(1):169-179.
    View in: PubMed
    Score: 0.011
  9. Crane PD, Sillau S, Dreher R, Fix R, Winters P, Van Coevering R, Engebretson E, Valdez B, Matthews E, Nair KV, Carlson AM, Piquet AL. Population-Based Study of the Epidemiology of Stiff Person Syndrome in a Large Colorado-Based Health System. Neurology. 2024 Dec 24; 103(12):e210078.
    View in: PubMed
    Score: 0.011
  10. Pellinen J, Sillau S, Morrison C, Maruff P, O'Brien TJ, Penovich P, French J, Knupp KG, Meador KJ. Engagement in online cognitive testing with the Cogstate brief battery among a multinational cohort of people with focal epilepsy. Epilepsy Behav. 2024 Oct; 159:109953.
    View in: PubMed
    Score: 0.010
  11. Kwon S, Sillau S, Corboy JR, Nair KV, Carlson AM. Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population. Ann Clin Transl Neurol. 2024 06; 11(6):1526-1534.
    View in: PubMed
    Score: 0.010
  12. Watson M, Cook K, Sillau S, Greenwell E, Libbon R, Strom L. Death of a loved one: A potential risk factor for onset of functional seizures. Epilepsy Behav. 2024 Jun; 155:109769.
    View in: PubMed
    Score: 0.010
  13. Pulver RL, Kronberg E, Medenblik LM, Kheyfets VO, Ramos AR, Holtzman DM, Morris JC, Toedebusch CD, Sillau SH, Bettcher BM, Lucey BP, McConnell BV. Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease. Alzheimers Dement. 2024 01; 20(1):301-315.
    View in: PubMed
    Score: 0.010
  14. Pellinen J, Pardoe H, Sillau S, Barnard S, French J, Knowlton R, Lowenstein D, Cascino GD, Glynn S, Jackson G, Szaflarski J, Morrison C, Meador KJ, Kuzniecky R. Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project. Epilepsia. 2023 Oct; 64(10):2761-2770.
    View in: PubMed
    Score: 0.010
  15. Barrera B, Simpson H, Engebretson E, Sillau S, Valdez B, Parra-González J, Winger RC, Epperson LA, Banks A, Pierce K, Spotts M, O'Gean K, Alvarez E, Gross R, Piquet AL, Schreiner T, Corboy JR, Pei J, Vollmer TL, Nair KV. Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis. Ann Clin Transl Neurol. 2023 04; 10(4):579-588.
    View in: PubMed
    Score: 0.009
  16. Fridman V, Sillau S, Bockhorst J, Smith K, Moroni I, Pagliano E, Pisciotta C, Piscosquito G, Laurá M, Muntoni F, Bacon C, Feely S, Grider T, Gutmann L, Shy R, Wilcox J, Herrmann DN, Li J, Ramchandren S, Sumner CJ, Lloyd TE, Day J, Siskind CE, Yum SW, Sadjadi R, Finkel RS, Scherer SS, Pareyson D, Reilly MM, Shy ME. Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study. Ann Neurol. 2023 03; 93(3):563-576.
    View in: PubMed
    Score: 0.009
  17. Watson M, Borland H, Baker S, Sillau S, Armon C, Strom L. Exploring the influence of telehealth on patient engagement with a multidisciplinary Non-Epileptic Seizure (NES) Clinic during the COVID-19 pandemic. Epilepsy Behav. 2022 06; 131(Pt A):108707.
    View in: PubMed
    Score: 0.009
  18. Carlson AM, Sollero CV, Nair KV, Sillau S, Wu Q, Gyang T, Li Z, Armstrong MJ. Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse population. Mult Scler Relat Disord. 2022 May; 61:103784.
    View in: PubMed
    Score: 0.009
  19. Brown MG, Sillau S, McDermott D, Ernst LD, Spencer DC, Englot DJ, González HFJ, Datta P, Karakis I, Becker D, Rolston JD, Arain A, Rao VR, Doherty M, Urban A, Drees C. Concurrent brain-responsive and vagus nerve stimulation for treatment of drug-resistant focal epilepsy. Epilepsy Behav. 2022 04; 129:108653.
    View in: PubMed
    Score: 0.009
  20. Leppert MH, Burke JF, Lisabeth LD, Madsen TE, Kleindorfer DO, Sillau S, Schwamm LH, Daugherty SL, Bradley CJ, Ho PM, Poisson SN. Systematic Review of Sex Differences in Ischemic Strokes Among Young Adults: Are Young Women Disproportionately at Risk? Stroke. 2022 02; 53(2):319-327.
    View in: PubMed
    Score: 0.009
  21. McConnell BV, Kronberg E, Teale PD, Sillau SH, Fishback GM, Kaplan RI, Fought AJ, Dhanasekaran AR, Berman BD, Ramos AR, McClure RL, Bettcher BM. The aging slow wave: a shifting amalgam of distinct slow wave and spindle coupling subtypes define slow wave sleep across the human lifespan. Sleep. 2021 10 11; 44(10).
    View in: PubMed
    Score: 0.009
  22. Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Mult Scler Relat Disord. 2021 Oct; 55:103170.
    View in: PubMed
    Score: 0.008
  23. Leppert MH, Ho PM, Burke J, Madsen TE, Kleindorfer D, Sillau S, Daugherty S, Bradley CJ, Poisson SN. Young Women Had More Strokes Than Young Men in a Large, United States Claims Sample. Stroke. 2020 11; 51(11):3352-3355.
    View in: PubMed
    Score: 0.008
  24. Vollmer BL, Nair K, Sillau S, Corboy JR, Vollmer T, Alvarez E. Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2020 09; 7(9):1466-1476.
    View in: PubMed
    Score: 0.008
  25. Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao G, Rodriguez-Morales AJ, Villamil-Gomez WE, Suárez JA, Shapiro L, Hotez PJ, Woc-Colburn L, DeSanto K, Rassi A, Franco-Paredes C, Henao-Martínez AF. Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 08 03; 3(8):e2015072.
    View in: PubMed
    Score: 0.008
  26. Fridman V, Sillau S, Acsadi G, Bacon C, Dooley K, Burns J, Day J, Feely S, Finkel RS, Grider T, Gutmann L, Herrmann DN, Kirk CA, Knause SA, Laurá M, Lewis RA, Li J, Lloyd TE, Moroni I, Muntoni F, Pagliano E, Pisciotta C, Piscosquito G, Ramchandren S, Saporta M, Sadjadi R, Shy RR, Siskind CE, Sumner CJ, Walk D, Wilcox J, Yum SW, Züchner S, Scherer SS, Pareyson D, Reilly MM, Shy ME. A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores. Neurology. 2020 03 03; 94(9):e884-e896.
    View in: PubMed
    Score: 0.008
  27. Berman BD, Groth CL, Sillau SH, Pirio Richardson S, Norris SA, Junker J, Brüggemann N, Agarwal P, Barbano RL, Espay AJ, Vizcarra JA, Klein C, Bäumer T, Loens S, Reich SG, Vidailhet M, Bonnet C, Roze E, Jinnah HA, Perlmutter JS. Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study. J Neurol Neurosurg Psychiatry. 2020 03; 91(3):314-320.
    View in: PubMed
    Score: 0.008
  28. Libbon R, Gadbaw J, Watson M, Rothberg B, Sillau S, Heru A, Strom L. The feasibility of a multidisciplinary group therapy clinic for the treatment of nonepileptic seizures. Epilepsy Behav. 2019 09; 98(Pt A):117-123.
    View in: PubMed
    Score: 0.007
  29. Leppert MH, Poisson SN, Sillau SH, Campbell JD, Ho PM, Burke JF. Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask. J Am Heart Assoc. 2019 03 19; 8(6):e010883.
    View in: PubMed
    Score: 0.007
  30. Vela-Duarte D, Nyberg E, Sillau S, Pate A, Castellanos P, Chastain DB, Franco-Paredes C, Henao-Martínez AF. Lacunar Stroke in Cryptococcal Meningitis: Clinical and Radiographic Features. J Stroke Cerebrovasc Dis. 2019 Jun; 28(6):1767-1772.
    View in: PubMed
    Score: 0.007
  31. Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL. Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology. 2019 02 12; 92(7):e723-e732.
    View in: PubMed
    Score: 0.007
  32. Vollmer BL, Nair KV, Sillau S, Corboy JR, Vollmer T, Alvarez E. Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol. 2019 02; 6(2):252-262.
    View in: PubMed
    Score: 0.007
  33. Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. Mult Scler Relat Disord. 2019 Jan; 27:383-390.
    View in: PubMed
    Score: 0.007
  34. Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease. Mov Disord. 2018 11; 33(11):1760-1768.
    View in: PubMed
    Score: 0.007
  35. Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E. The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis. J Neurol Sci. 2018 07 15; 390:89-93.
    View in: PubMed
    Score: 0.007
  36. Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018 06; 128(6):1713-1718.
    View in: PubMed
    Score: 0.006
  37. Freeman JL, Davern MS, Oushy S, Sillau S, Ormond DR, Youssef AS, Lillehei KO. Spheno-Orbital Meningiomas: A 16-Year Surgical Experience. World Neurosurg. 2017 Mar; 99:369-380.
    View in: PubMed
    Score: 0.006
  38. Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration. World Neurosurg. 2016 Dec; 96:47-57.
    View in: PubMed
    Score: 0.006
  39. Burfeind G, Seymour D, Sillau SH, Zittleman L, Westfall JM. Provider perspectives on integrating primary and behavioral health: a report from the High Plains Research Network. J Am Board Fam Med. 2014 May-Jun; 27(3):375-82.
    View in: PubMed
    Score: 0.005
  40. Regalia K, Zheng P, Sillau S, Aggarwal A, Bellevue O, Fix OK, Prinz J, Dunn S, Biggins SW. Demographic factors affect willingness to register as an organ donor more than a personal relationship with a transplant candidate. Dig Dis Sci. 2014 Jul; 59(7):1386-91.
    View in: PubMed
    Score: 0.005
  41. Elwell D, Junker S, Sillau S, Aagaard E. Refugees in Denver and their perceptions of their health and health care. J Health Care Poor Underserved. 2014 Feb; 25(1):128-41.
    View in: PubMed
    Score: 0.005
  42. Molina WR, Kim FJ, Spendlove J, Pompeo AS, Sillau S, Sehrt DE. The S.T.O.N.E. Score: a new assessment tool to predict stone free rates in ureteroscopy from pre-operative radiological features. Int Braz J Urol. 2014 Jan-Feb; 40(1):23-9.
    View in: PubMed
    Score: 0.005
  43. Fountain CR, Mudd PA, Ramakrishnan VR, Sillau SH, Kingdom TT, Katial RK. Characterization and treatment of patients with chronic rhinosinusitis and nasal polyps. Ann Allergy Asthma Immunol. 2013 Nov; 111(5):337-41.
    View in: PubMed
    Score: 0.005
  44. Salazar M, Stinson KE, Sillau SH, Good L, Newman LS. Web-based electronic health records improve data completeness and reduce medical discrepancies in employee vaccination programs. Infect Control Hosp Epidemiol. 2012 Jan; 33(1):84-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)